A cross-sectional community study of serum iron measures and cognitive status in older adults

Journal of Alzheimer's Disease

Volumn 20, Issue 2, 2010, Pages 617-623

  Milward, Elizabeth A ^a   Bruce, David G ^b   Knuiman, Matthew W ^c   Divitini, Mark L ^c   Cole, Michelle ^b   Inderjeeth, Charles A ^b   Clarnette, Roger M ^d   Maier, Graham ^c   Jablensky, Assen ^c   Olynyk, John K ^b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d FREMANTLE HOSPITAL   (Australia)

Author keywords

Alzheimer's disease; cognition; dementia; ferritin; iron

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

ADULT; AGED; ARTICLE; AUSTRALIA; CAMBRIDGE COGNITIVE TEST; COGNITION; CONTROLLED STUDY; DEMENTIA; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; TRANSFERRIN BLOOD LEVEL;

EID: 77954473478     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-1402     Document Type: Article

References (41)

1. Youdim MB, Yehuda S (2000) The neurochemical basis of cognitive deficits induced by brain iron deficiency: involvement of dopamine-opiate system. Cell Mol Biol (Noisy-legrand) 46, 491-500.
2. Zecca L, Youdim MBH, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5, 863-873.
3. Richardson DR (2004) Novel chelators for central nervous system disorders that involve alterations in the metabolism of iron and other metal ions. Ann N Y Acad Sci 1012, 326-341.
4. Liu G, Mena P, Harris PLR, Rolston RK, Perry G, Smith MA (2006) Nanoparticle iron chelators: A new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance. Neurosci Lett 406, 189-193
5. McNeill A, Pandolfo M, Kuhne J, Shang H, Miyajimad H (2008) The neurological presentation of ceruloplasmin gene mutations. Eur Neurol 60, 200-205.
6. Stankiewicz JM, Brass SD (2009) Role of iron in neurotoxicity: a cause for concern in the elderly? Curr Opin Clin Nutr Metab Care 12, 22-29.
7. Fischer P, Gotz ME, DanielczykW, GsellW, Riederer P (1997) Blood transferrin and ferritin in Alzheimer's disease. Life Sci 60, 2273-2278.
8. LeVine SM (1997) Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res 760, 298-303.
9. Bartzokis G, Sultzer D, Cummings J, Holt LE, Hance DB, Henderson VW, Mintz J (2000) In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. Arch Gen Psychiatry 57, 47-53.
10. Kaur D, Andersen J (2004) Does cellular iron dysregulation play a causative role in Parkinson's disease? Ageing Res Rev 3, 327-343.
11. Gregory A, Polster BJ, Hayflick S (2009) Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J Med Genet 46, 73-80.
12. Zhou B,Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ (2001)Anovel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 28, 345-349.
13. Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, Chinnery PF, Coulthard A, Jackson MJ, Jackson AP, McHale DP, Hay D, BarkerWA, Markham AF, Bates D, Curtis A, Burn J (2001) Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet 28, 350-354.
14. Levi S, Cozzi A, Arosio P (2005) Neuroferritinopathy: a neurodegenerative disorder associated with L-ferritin mutation. Best Pract Res Clin Haematol 18, 265-276.
15. Logan S, Martins S, Gilbert R (2001) Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron deficiency anaemia. Cochrane Database Syst Rev CD001444.
16. Sachdev H, Gera T, Nestel P (2005) Effect of iron supplementation on mental and motor development in children: systematic review of randomised controlled trials. Public Health Nutr 8, 117-132.
17. McCann JC, Ames BN (2007) An overview of evidence for a causal relation between iron deficiency during development and deficits in cognitive or behavioral function. AmJ Clin Nutr 85, 931-945.
18. Smorgon C, Mari E, Atti AR, Dalla Nora E, Zamboni PF, Calzoni F, Passaro A, Fellin R (2004) Trace elements and cognitive impairment: an elderly cohort study. Arch Gerontol Geriatr Suppl 9, 393-402.
19. Lam PK, Kritz-Silverstein D, Barrett Connor E, Milne D, Nielsen F, Gamst A, Morton D,WingardD(2008) Plasma trace elements and cognitive function in older men and women: the Rancho Bernardo study. J Nutr Health Aging 12, 22-27.
20. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW (1999) A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 341, 718-724.
21. Knuiman MW, Divitini ML, Olynyk JK, Cullen DJ, Bartholomew HC (2003) Serum ferritin and cardiovascular disease: a 17-year follow-up study in Busselton,Western Australia. Am J Epidemiol 158, 144-149.
22. Huppert FA, Brayne C, Gill C, Paykel ES, Beardsall L (1995) CAMCOG-a concise neuropsychological test to assist dementia diagnosis: socio-demographic determinants in an elderly population sample. Br J Clin Psychol 34, 529-541.
23. Roth M, Huppert FA, Mountjoy CQ, TymE (1998) CAMDEXR. The Cambridge examination for mental disorders of the elderly - revised, Cambridge University Press, Cambridge.
24. Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43, 2412-2414.
25. Dale JC, Burritt MF, Zinsmeister AR (2002) Diurnal variation of serum iron, iron-binding capacity, transferrin saturation, and ferritin levels. Am J Clin Pathol 117, 802-808.
26. Mei Z, Cogswell ME, Parvanta I, Lynch S, Beard JL, Stoltzfus RJ, Grummer-Strawn LM (2005) Hemoglobin and ferritin are currently the most efficient indicators of population response to iron interventions: an analysis of nine randomized controlled trials. J Nutr 135, 1974-1980.
27. Zimmermann MB (2008) Methods to assess iron and iodine status. Brit J Nutr 99(Suppl 3), S2-S9.
28. Guyader D, Jacquelinet C, Moirand R, Turlin B, Mendler MH, Chaperon J, David V, Brissot P, Adams P, Deugnier Y (1998) Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 115, 929-936.
29. Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, Allen KJ, McLaren CE, Bahlo M, Nisselle AE, Vulpe CD, Anderson GJ, Southey MC, Giles GG, English DR, Hopper JL, Olynyk JK, Powell LW, Gertig DM (2008) Ironoverload- related disease in HFE hereditary hemochromatosis. N Engl J Med 358, 221-230.
30. Whitlock EP, Garlitz BA, Harris EL, Beil TL, Smith PR (2006) Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 145, 209-223.
31. Ayonrinde OT, Milward EA, Chua AC, Trinder D, Olynyk JK (2008) Clinical perspectives on hereditary hemochromatosis. Crit Rev Clin Lab Sci 45, 451-484.
32. Crooks C, West J, Solaymani-Dodaran M, Card TR (2009) The epidemiology of haemochromatosis: a population-based study. Aliment Pharmacol Ther 29, 183-192.
33. Milward EA, Baines SK, Knuiman MW, Bartholomew HC, Divitini ML, Ravine DG, Bruce DG, Olynyk JK (2008) Noncitrus fruits as novel dietary environmental modifiers of iron stores in people with or without HFE gene mutations. Mayo Clin Proc 83, 543-549.
34. Monchi O, Petrides M, Strafella AP, Worsley KJ, Doyon J (2006) Functional role of the basal ganglia in the planning and execution of actions. Ann Neurol 59, 257-264.
35. Melrose RJ, Poulin RM, Stern CE (2007) An fMRI investigation of the role of the basal ganglia in reasoning. Brain Res 1142, 146-158.
36. Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, White CL 3rd, Schneider JA, Grinberg LT, Halliday G, Duyckaerts C, Lowe JS, Holm IE, Tolnay M, Okamoto K,YokooH, Murayama S,Woulfe J, Munoz DG, DicksonDW, Ince PG, Trojanowski JQ, Mann DM (2007) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 114, 5-22.
37. Cahn-Weiner DA, Malloy PF, Boyle PA, Marran M, Salloway S (2000) Prediction of functional status from neuropsychological tests in community-dwelling elderly individuals. Clin Neuropsychol 14, 187-195.
38. Bell-McGinty S, Podell K, FranzenM,Baird AD,WilliamsMJ (2002) Standard measures of executive function in predicting instrumental activities of daily living in older adults. Int J Geriatr Psychiatry 17, 828-834.
39. Olynyk JK, Gan E, Tan T (2009) Predicting iron overload in hyperferritinemia. Clin Gastroenterol Hepatol 7, 359-362.
40. House MJ, St Pierre TG, Milward EA, Bruce DG, Olynyk JK (2010) Relationship between brain R2 and liver and serum iron concentrations in elderly men. Magn Reson Med 63, 275-281.
41. Burn J, Chinnery PF (2006) Neuroferritinopathy. Semin Pediatr Neurol 13, 176-181.